Leading the Way in Treating Rare and Serious Diseases CSL Behring discovers, develops and delivers innovative therapies for people living with a range of rare and serious health conditions. Securing Health for All of Us CSL Seqirus is a major contributor to the prevention of influenza globally and a transcontinental partner in pandemic preparedness. Changing the Game in Iron Deficiency and Nephrology CSL Vifor is a global partner of choice for pharmaceuticals and innovative leading therapies in iron deficiency and nephrology. + READ MORE ON PAGE 16 + READ MORE ON PAGE 17 + READ MORE ON PAGE 18 Australia Japan China Germany Netherlands United Kingdom Spain Switzerland Italy Hungary 3 CSL Limited Annual Report 2024/25
RkJQdWJsaXNoZXIy MjE2NDg3